Literature DB >> 12921761

Detection of IgE anti-parvovirus B19 and increased CD23+ B cells in parvovirus B19 infection: relation to Th2 cytokines.

Martin H Bluth1, Kevin B Norowitz, Seto Chice, Vipin N Shah, Maja Nowakowski, Alan S Josephson, Helen G Durkin, Tamar A Smith-Norowitz.   

Abstract

The immune profile of a parvovirus B19-infected patient (male, 8 years old) was studied on day 0 (initial presentation) and on days 14 and 210 post symptom presentation (psp). Before infection, the patient was skin test positive to various allergens, including ragweed and tree and grass pollens, and had a serum IgE level of 150 IU/mL. On day 0, the patient was diagnosed as parvovirus B19 infected, as judged by the presence of IgG anti-parvovirus Abs in serum (EIA) and presentation of "slap cheek" rash. The patient's serum IgE level increased from 150 IU/mL before infection to 256 IU/mL on day 0, was 233 IU/mL on day 14, and returned to preinfection levels on day 210. In contrast, there was little change in the levels of serum IgM, IgG, or IgA (nephelometry). IgE anti-parvovirus B19 protein (VP-N) was detected in serum (Western blot) on days 0, 14, and 210, despite the decrease in total IgE on day 210. Although there was no increase in total numbers of blood CD23+ B cells on day 0, by day 14 the numbers of these cells increased dramatically (93%), remaining high on day 210. In contrast, there were virtually no changes in total numbers of CD4+ and CD8+ T cells or CD16/56+ NK precursor cells on days 0-210. On day 0, when IgG and IgE anti-parvovirus were detected in serum, patient's peripheral blood mononuclear cells (PBMC) expressed mRNA for the Th2 cytokines IL-4 and IL-10, but not for the Th1 cytokines IFN-gamma or IL-2. However, by day 14 psp, PBMC expressed mRNA for the Th1 cytokines IFN-gamma and IL-2, as well as for IL-4 and IL-10. This is the first demonstration of the existence of IgE anti-parvovirus B19 Ab. The presence of IgE anti-parvovirus B19 Ab in serum on day 0 and its persistence in serum 7 months psp suggests that IgE anti-parvovirus may be useful in prognosis of parvovirus B19 infection. Our results reinforce the idea that IgE, in general, may play a major role in anti-viral immunity, perhaps in conjunction with CD23+ cells. The results further suggest that clearance of this infection is accompanied by a switch to Th1 cytokines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12921761     DOI: 10.1016/s1521-6616(03)00098-6

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  11 in total

Review 1.  Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements.

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Gabriele Calizzani; Fabio Candura; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-04       Impact factor: 3.443

2.  T helper cell-mediated interferon-gamma expression after human parvovirus B19 infection: persisting VP2-specific and transient VP1u-specific activity.

Authors:  R Franssila; J Auramo; S Modrow; M Möbs; C Oker-Blom; P Käpylä; M Söderlund-Venermo; K Hedman
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

3.  Cytokine responses in acute and persistent human parvovirus B19 infection.

Authors:  A Isa; A Lundqvist; A Lindblom; T Tolfvenstam; K Broliden
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

Review 4.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

5.  Increased seroprevalence of Enterovirus 71 IgE antibodies in asthmatic compared with non-asthmatic children.

Authors:  T A Smith-Norowitz; S Carvajal-Raga; J Weedon; R Joks; K B Norowitz; D Weaver; H G Durkin; M R Hammerschlag; S Kohlhoff
Journal:  Ir J Med Sci       Date:  2016-07-20       Impact factor: 1.568

6.  Increased expression and secretion of interleukin-6 in human parvovirus B19 non-structural protein (NS1) transfected COS-7 epithelial cells.

Authors:  T-C Hsu; B-S Tzang; C-N Huang; Y-J Lee; G-Y Liu; M-C Chen; G J Tsay
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

7.  Long term persistence of IgE anti-influenza virus antibodies in pediatric and adult serum post vaccination with influenza virus vaccine.

Authors:  Tamar A Smith-Norowitz; Darrin Wong; Melanie Kusonruksa; Kevin B Norowitz; Rauno Joks; Helen G Durkin; Martin H Bluth
Journal:  Int J Med Sci       Date:  2011-03-18       Impact factor: 3.738

8.  The effects of human parvovirus VP1 unique region in a mouse model of allergic asthma.

Authors:  Shyh-Ren Chiang; Chia-Yun Lin; Der-Yuan Chen; Hui-Fang Tsai; Xin-Ci Lin; Tsai-Ching Hsu; Bor-Show Tzang
Journal:  PLoS One       Date:  2019-05-14       Impact factor: 3.240

9.  Long Term Persistence of IgE Anti-Varicella Zoster Virus in Pediatric and Adult Serum Post Chicken Pox Infection and after Vaccination with Varicella Virus Vaccine.

Authors:  Tamar A Smith-Norowitz; Joby Josekutty; Jonathan I Silverberg; Hadar Lev-Tov; Yitzchok M Norowitz; Stephan Kohlhoff; Maja Nowakowski; Helen G Durkin; Martin H Bluth
Journal:  Int J Biomed Sci       Date:  2009-12

10.  Long-term persistence of IgE anti-influenza A HIN1 virus antibodies in serum of children and adults following influenza A vaccination with subsequent H1N1 infection: a case study.

Authors:  Tamar A Smith-Norowitz; Melanie Kusonruksa; Darrin Wong; Moshe M Norowitz; Rauno Joks; Helen G Durkin; Martin H Bluth
Journal:  J Inflamm Res       Date:  2012-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.